Major Acquisition Alert: William Chang Acquires $268K In Semler Scientific Stock Options

In a recent SEC filing, it was disclosed that William Chang, Director at Semler Scientific SMLR, made a noteworthy acquisition of company stock options on May 29,.

What Happened: Chang, Director at Semler Scientific, engaged in a derivative transaction according to a Form 4 filing on Wednesday with the U.S. Securities and Exchange Commission. This involved the acquisition of stock options for 27,000 shares of SMLR, providing the right to purchase the company's stock at an exercise price of $23.32 per share.

The Thursday morning market activity shows Semler Scientific shares up by 3.13%, trading at $33.25. This implies a total value of $268,110 for Chang's 27,000 shares.

All You Need to Know About Semler Scientific

Semler Scientific Inc is a United States based company that is engaged in providing technology solutions to improve the clinical effectiveness and efficiency of healthcare providers. It focuses on developing, manufacturing, and marketing proprietary products and services that assist customers, including insurance plans, physicians, and risk assessment groups, in evaluating and treating chronic diseases. The company markets its vascular-testing product under the QuantaFlo brand, which is a four-minute in-office blood flow test.

Semler Scientific: Financial Performance Dissected

Revenue Challenges: Semler Scientific's revenue growth over 3 months faced difficulties. As of 31 March, 2024, the company experienced a decline of approximately -12.65%. This indicates a decrease in top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Health Care sector.

Interpreting Earnings Metrics:

• Gross Margin: The company sets a benchmark with a high gross margin of 92.16%, reflecting superior cost management and profitability compared to its peers.

• Earnings per Share (EPS): The company excels with an EPS that surpasses the industry average. With a current EPS of 0.88, Semler Scientific showcases strong earnings per share.

Debt Management: Semler Scientific's debt-to-equity ratio is below the industry average. With a ratio of 0.0, the company relies less on debt financing, maintaining a healthier balance between debt and equity, which can be viewed positively by investors.

Insights into Valuation Metrics:

• Price to Earnings (P/E) Ratio: Semler Scientific's P/E ratio of 11.58 is below the industry average, suggesting the stock may be undervalued.

• Price to Sales (P/S) Ratio: With a higher-than-average P/S ratio of 3.81, Semler Scientific's stock is perceived as being overvalued in the market, particularly in relation to sales performance.

• EV/EBITDA Analysis (Enterprise Value to its Earnings Before Interest, Taxes, Depreciation & Amortization): With a lower-than-industry-average EV/EBITDA ratio of 6.77, Semler Scientific presents a potential value opportunity, as investors are paying less for each unit of EBITDA.

Market Capitalization Perspectives: The company's market capitalization falls below industry averages, signaling a relatively smaller size compared to peers. This positioning may be influenced by factors such as perceived growth potential or operational scale.

Now trade stocks online commission free with Charles Schwab, a trusted and complete investment firm.

Unmasking the Significance of Insider Transactions

Insightful as they may be, insider transactions should be considered alongside a thorough examination of other investment criteria.

Exploring the legal landscape, an "insider" is defined as any officer, director, or beneficial owner holding more than ten percent of a company's equity securities, as stipulated by Section 12 of the Securities Exchange Act of 1934. This encompasses executives in the c-suite and major hedge funds. These insiders are required to report their transactions through a Form 4 filing, which must be submitted within two business days of the transaction.

Highlighted by a company insider's new purchase, there's a positive anticipation for the stock to rise.

But, insider sells may not necessarily indicate a bearish view and can be motivated by various factors.

Exploring Key Transaction Codes

When analyzing transactions, investors tend to focus on those in the open market, detailed in Table I of the Form 4 filing. A P in Box 3 denotes a purchase,while S signifies a sale. Transaction code C signals the conversion of an option, and transaction code A denotes a grant, award, or other acquisition of securities from the company.

Check Out The Full List Of Semler Scientific's Insider Trades.

This article was generated by Benzinga's automated content engine and reviewed by an editor.